Lipopolysaccharide, also known as endotoxin, is the major component of the outer membranes of gram-negative bacteria. It consists of three moieties: lipid A, the core oligosaccharide, and the O-specific polysaccharide (O antigen). The O antigen is composed of a number of repeats of an oligosaccharide unit (O unit). The O unit usually contains 2 to 8 residues from a broad range of monosaccharides and their derivatives (6, 9) . The O antigen is one of the most varied cell constituents due to the variation in the types of sugars present, the arrangement of the sugars within the O unit, and the linkages between sugars. More than 180 O-antigen forms have been recognized in Escherichia coli (including Shigella) (33) . The O antigen is a major target of the immune system and bacteriophages, and O-antigen variation is important for bacterial survival and pathogenicity (31) . Several studies have indicated that the composition of the O antigen might be an indicator of virulence potential (18) , and some O-antigen forms, including that in E. coli O7, are most commonly found in pathogenic E. coli strains (25) . Shigella strains are important human pathogens causing diseases such as diarrhea and bacillary dysentery (26) . Genes for the synthesis of the O antigen are normally located in a gene cluster which maps between galF and gnd on the chromosomes of E. coli and Shigella (32) . Many O-antigen gene clusters have been sequenced, with gene functions proposed (http://www.mmb.usyd.edu.au/BPGD/default.htm). Biosynthetic pathways for several O-antigen sugar precursors, such as UDP-L-FucNAc, have been characterized biochemically (15, 16, 22, 27, 30, 36) .
The O antigen of Shigella dysenteriae type 7 is composed of a tetrasaccharide O unit containing a residue of 4-(N-acetylglycyl)amino-4,6-dideoxy-D-glucose (D-Qui4NGlyAc) (17) . The same O-antigen structure is also present in E. coli O121, which belongs to Shiga toxin-producing E. coli causing hemolytic uremic syndrome (28, 38) . The E. coli O7 O antigen is composed of a pentasaccharide O unit containing a residue of 4-acetamido-4,6-dideoxy-D-glucose (D-Qui4NAc) (19) . Both Qui4NGlyAc and Qui4NAc belong to dideoxy(acetylglycyl/ acetyl)amino hexoses, which are sugars not often found in studied polysaccharides.
In our previous study, the O-antigen gene cluster of S. dysenteriae type 7 was sequenced and three genes from this organism, rmlA D7 , rmlB D7 , and vioA D7 , were proposed to be responsible for the synthesis of dTDP-D-Qui4N (the nucleotide-activated precur-sor of D-Qui4NGlyAc) (10) . Glucose-1-phosphate thymidyltransferase (RmlA) catalyzes the conversion of glucose-1-phosphate to dTDP-D-glucose (dTDP-D-Glc), which is then converted to dTDP-4-keto-6-deoxy-D-glucose (dTDP-D-Glc4O) by dTDP-Dglucose 4,6-dehydratase (RmlB). Both reaction steps have been biochemically verified in a number of bacterial strains (11, 30) . VioA, a putative sugar aminotransferase (SAT) of the DegT/ DnrJ/EryC1/StrS family, was proposed to catalyze the conversion of dTDP-D-Glc4O to dTDP-D-Qui4N. The E. coli O7 O-antigen gene cluster was also sequenced (20) , and the biosynthetic pathway for dTDP-D-Qui4NAc was proposed, in which dTDP-DQui4NAc is derived from dTDP-D-Qui4N by a transacetylation reaction catalyzed by a putative acetyltransferase of the NodLLacA family, VioB O7 (20) . However, the functions of VioA and VioB have not yet been confirmed.
In this study, we characterized the biosynthetic pathways of dTDP-D-Qui4N and dTDP-D-Qui4NAc. Genes encoding RmlA, RmlB, VioA, and VioB were cloned from S. dysenteriae type 7 (rmlA D7 , rmlB D7 , and vioA D7 ) and/or E. coli O7 (vioA O7 and vioB O7 ), and the gene products were overexpressed and purified as His-tagged fusion proteins. In vitro enzymatic reactions were carried out, and the products were analyzed by spectroscopic methods. VioA was identified as a novel aminotransferase catalyzing the conversion of dTDP-D-Glc4O to dTDP-D-Qui4N in S. dysenteriae type 7 and E. coli O7, and VioB was identified as a novel acetyltransferase catalyzing the conversion of dTDP-D-Qui4N to dTDP-D-Qui4NAc in E. coli O7. Enzymatic properties of VioA and VioB were investigated, and differences between VioA D7 and VioA O7 are discussed.
MATERIALS AND METHODS
Materials. ␣-D-Glucose-1-phosphate, dTTP, dTDP-D-Glc, pyridoxal-5-phosphate (PLP), inorganic pyrophosphatase, acetyl coenzyme A (acetyl-CoA), SHCoA, and aminooxy acetic acid were purchased from Sigma-Aldrich (St. Louis, MO), methanol and acetonitrile were purchased from Fisher (Pittsburgh, PA), and acetic acid was purchased from Fluka (Buchs SG, Switzerland). All the chemicals were at the highest purity available. Restriction enzymes and recombinant Taq DNA polymerase were from TaKaRa (Japan), and T4 DNA ligase was from Promega (Madison, WI). Other chemicals and reagents were from Sangon Co., Ltd. (Shanghai, China). Bacterial strains and plasmids used are listed in Table 1 .
Cloning and plasmid construction. Chromosomal DNA was prepared as previously described (3). The rmlA D7 , rmlB D7 , and vioA D7 genes were PCR amplified from strain G1222, and the vioA O7 and vioB O7 genes were amplified from strain G1112. Primers used are listed in Table 1 . A total of 30 cycles (25 cycles for vioA O7 ) were performed using the following conditions: denaturation at 95°C for 30 s, annealing at 50°C (55°C for vioA O7 ) for 30 s, and extension at 72°C for 1 min in a final volume of 25 l. The amplified genes were cloned into pET28a ϩ to construct plasmids pLW1048 (containing rmlA D7 ), pLW1051 (containing rmlB D7 ), pLW1049 (containing vioA D7 ), pLW1195 (containing vioA O7 ), and pLW1155 (containing vioB O7 ) ( Table 1) , and the inserts were sequenced by Tianjin Biochip Cooperation using an ABI 3730 sequencer.
Protein expression and purification. E. coli BL21(DE3) carrying each of the recombinant plasmids was grown overnight at 37°C in LB medium containing 50 g/ml kanamycin. The overnight culture (5 ml) was inoculated into 500 ml of fresh LB medium and grown until the A 600 reached 0.6. The expression of RmlA D7 , VioA D7 , and VioB O7 was induced with 0.1 mM isopropyl-␤-Dthiogalactopyranoside (IPTG) at 37°C for 4 h, and expression of RmlB D7 and VioA O7 was induced with 0.1 mM IPTG at 12°C for 8 h and at 25°C for 4 h. After IPTG induction, cells were harvested by centrifugation, washed with 50 mM Tris-HCl (pH 8.0) containing 300 mM NaCl and 10 mM imidazole, resuspended into 5 ml of the same buffer, and sonicated. The cell debris was removed by centrifugation, and total soluble proteins in the supernatant were collected. The His 6 -tagged fusion proteins in the supernatant were purified by nickel ion affinity chromatography with a chelating Sepharose Fast Flow (GE 
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Healthcare) column according to the manufacturer's instructions. Unbound proteins were washed out with 100 ml of wash buffer (50 mM Tris-HCl, pH 8.0, 300 mM NaCl, and 25 mM imidazole). The fusion proteins were eluted with 3 ml of elution buffer (50 mM Tris-HCl, pH 8.0, 300 mM NaCl, and 250 mM imidazole) and dialyzed overnight against 50 mM potassium phosphate buffer (pH 7.4) at 4°C. Protein concentration was determined by the Bradford method. Enzyme activity assays. The reaction mixture for RmlA contained 50 mM potassium phosphate buffer (pH 7.4), 5 mM MgCl 2 , 4 mM ␣-D-glucose-1-phosphate, 4 mM dTTP, 0.02 U inorganic pyrophosphatase, and a 0.13 M concentration of purified RmlA D7 (39) . The reaction mixture for RmlB contained 50 mM potassium phosphate buffer (pH 7.4), 5 mM MgCl 2 , 8 mM dTDP-D-Glc, and a 2.65 M concentration of purified RmlB D7 (39) . To assay the VioA activity, the RmlB mixture was supplemented with 50 mM Lglutamate (L-Glu), 0.2 mM PLP, and 2 M VioA D7 or 0.66 M VioA O7 after the RmlB reaction (30) . To assay the VioB activity, the VioA mixture was supplemented with 2.5 mM acetyl-CoA and 1.93 M VioB O7 after the VioA reaction (30) . All reactions were carried out in a final volume of 50 l at 37°C for 2 h unless otherwise indicated. Products from each of the reactions were analyzed by capillary electrophoresis (CE), electrospray ionization mass spectrometry (ESI-MS), and nuclear magnetic resonance spectroscopy (NMR). Enzyme activities were indicated by the conversion of substrates into products.
Kinetic-parameter measurements. To measure K m and V max values of VioA D7 and VioA O7 , reactions were carried out with various concentrations of dTDP-D-Glc4O (0.05 to 2 mM for VioA D7 Determination of temperature optimum, divalent-cation effects, and amino donor requirements for VioA D7 , VioA O7 , and VioB O7 . To determine the temperature optimum for each enzyme, reactions were carried out at 4 
activities were examined by CE, and the data are the averages of results from three independent experiments. CE. CE was performed using a Beckman Coulter P/ACE MDQ CE system with a photoelectricity diode array detector (Beckman Coulter, CA). The capillary was bare silica (inside diameter, 75 m by 57 cm, with the detector at 50 cm) and conditioned before each run by washing it with 0.1 M NaOH first, with deionized water next, and with 25 mM borate-sodium hydroxide, pH 9.4 (used as the mobile phase) last for 2 min each time. Samples were loaded by pressure injection at 0.5 lb/in 2 for 10 s, and separation was carried out at 20 kV. Peak integration and trace alignments were done with Beckman P/ACE Station software (32 Karat, version 5.0). Conversion ratios were calculated by comparing the peak areas of the substrate and product.
ESI-MS and tandem MS. The reaction mixtures of RmlB D7 , VioA D7 , and VioB O7 were separated by reverse-phase high-performance liquid chromatography (RP-HPLC) using a BioCAD 700E perfusion chromatography workstation (Applied Biosystems, CA) with an Venusil MP-C18 column (5-m particle size, 4.6 by 250 mm) (Agela Technologies, Inc.). The mobile phase used was composed of 10% acetonitrile and 90% 50 mM triethylamine-acetic acid (pH 6.0), and the flow rate was 0.6 ml/min. Fractions containing the expected products were collected, lyophilized, and redissolved in 50% methanol before they were injected into a Finnigan LCQ Advantage MAX ion trap mass spectrometer (Thermo Electron, CA) in the negative mode (4.5 kV, 250°C) for ESI-MS analysis. For second and third MS (MS2 and MS3) analyses, nitrogen was used as the collision gas and helium as the auxiliary gas and collision energies used were typically 20 to 30 eV.
NMR spectroscopy. A sample of dTDP-D-Qui4NAc (0.2 mg) was deuterium exchanged by freeze-drying from D 2 O, dissolved in 99.96% D 2 O (150 l), and examined using a Shigemi (Japan) microtube. NMR spectra were recorded on a Bruker DRX-500 spectrometer (Germany) at 30°C using internal sodium trimethylsilyl-[2,2,3,3-2 H 4 ]propanoate (␦ H 0.00) and external aqueous 85% H 3 PO 4 (␦ P 0) as references. Two-dimensional NMR spectra were obtained using standard pulse sequences from the manufacturer, and the XWinNMR 2.6 program (Bruker) was used to acquire and process the NMR data. A mixing time of 200 ms was used in a total correlation spectroscopy (TOCSY) experiment, which was employed to correlate all coupled protons within each spin system (4). 
kDa).
In vitro characterization of dTDP-D-Qui4N and dTDP-DQui4NAc biosynthetic pathways by CE. Biosynthetic pathways of dTDP-D-Qui4N and dTDP-D-Qui4NAc were characterized by carrying out each of the enzymatic steps sequentially in a single reaction mixture containing ␣-D-glucose-1-phosphate as the initial substrate and by analyzing each of the reaction products by CE. When RmlA D7 , the first enzyme of the pathways, was added, a peak eluted at the same time (9.5 min) that the standard dTDP-D-Glc ( Fig. 2A and B) was produced, confirming the function of RmlA D7 as RmlA. When the second enzyme, RmlB D7 , was added, the peak corresponding to dTDP-D-Glc was converted to a peak that eluted at 10.4 min, indicating that the emerging peak is the product of RmlB (Fig.  2C) . The peak at 10.4 min was converted to a new peak that eluted at 9.3 min when L-glutamate, PLP, and purified VioA D7 were added next (Fig. 2D ), and this peak had not appeared when VioA D7 was heat denatured before the addition or in the presence of the PLP-dependent aminotransferase inhibitor aminooxy acetic acid (12; data not shown). The same was found when purified VioA O7 was used instead of VioA D7 (Fig.  2E) . These results indicated that the peak at 9.3 min was the product of VioA D7 and VioA O7 and that both enzymes are PLP-dependent aminotransferases catalyzing the transfer of an amino group onto the RmlB product. The peak at 9.3 min disappeared almost completely, and another new peak that migrated at 8.8 min appeared when acetyl-CoA and purified VioB O7 were added to the reaction mixture (Fig. 2F) . Conversion of acetyl-CoA to SH-CoA was also detected by comparing the migration times of the peaks before and after the reaction with those of the standard chemicals ( Fig. 2G and H) , indicating that the acetyl group was transferred to the VioA product. No products were produced when VioB O7 was heat denatured before the addition (data not shown).
Structural identification of the reaction products by ESI-MS and tandem MS. Products of RmlB D7 , VioA D7 , and VioB O7 were separated and purified by RP-HPLC (data not shown). Fractions containing each of the RmlB, VioA, and VioB products were collected and analyzed by ESI-MS (Fig.  3A to C) . Ion peaks at m/z 545.20 (Fig. 3A) , 546.27 (Fig. 3B) , and 588.20 ( Fig. 3C) were obtained, which are in agreement with the expected masses for dTDP-D-Glc4O (m/z 544.32), dTDP-D-Qui4N (m/z 547.34), and dTDP-D-Qui4NAc (m/z 589.38). Ion peaks representing each sugar plus one or two Na ϩ ions were also detected ( Fig. 3A to C ; Table 2 ). Further analyses by MS2 and MS3 were performed to confirm the molecular mass of the VioB O7 product, the end product of the Qui4NAc biosynthetic pathway. MS2 analysis of the product peak at m/z 588.20 produced peaks at m/z 545.26, 401.11, 383.00, and 321.13, matching the masses of the dTDP-D-Qui4NAc minus acetyl group, dTDP-H 2 O, dTDP, and the Qui4NAc-PO 3 -PO 3 minus acetyl group, respectively. Peaks corresponding to dTDP-D-Qui4NAc minus CH 3 -CO-NH-CH-CH-CH 3 (m/z 489.91) and Qui4NAc-PO 3 -PO 3 minus CH 3 -CO-NH-CH-CH-CH 3 (m/z 266.31) resulting from fragmentation of the hexose rings between C-3-C-4 and C-5-O were also detected ( Fig. 3D; Table 2 ). When the ion peak at m/z 321.13 was selected as a parent peak for MS3 analysis, a peak at m/z 277.13, which matched the fragment of Qui4NAc-PO 3 -PO 3 minus acetyl and CH 3 -CH-O, resulted from fragmentation of the hexose rings between C-4-C-5 and O-C-1 ( Fig. 3E ; Table  2 ). These results indicated that an acetamido group had been added to the C-4 position of the glucose moiety of the VioB O7 product, confirming the identity of Qui4NAc as the product of VioB O7 . Fragments corresponding to each peak are depicted in Table 2 .
Determination of the configuration at C-4 of the hexose unit in the VioB O7 product by NMR spectroscopy. The 1 H NMR spectrum of dTDP-D-Qui4NAc was assigned using two-dimensional 1 H, 1 H COSY and TOCSY experiments. In the TOCSY spectrum (Fig. 4) , cross-peaks were generated between all coupled protons within each spin system, including those between H-1 and H-2-H-6 of the QuiNAc moiety at ␦ 5.58 (H-1)/3.61 (H-2), 3.77 (H-3), 3.63 (H-4), 4.06 (H-5) , and 1.18 (H-6); between H-1Ј and H-2Ј-H-5Ј of 2Ј-deoxyribose in the dTDP moiety at ␦ 6.35 (H-1)/2.38 (H-2), 4.63 (H-3), and 4.18 (H-4-H-5a and -H-5b); and between H-6 and CH 3 of thymine at ␦ 7.74/1.93. The assigned chemical shifts were in good agreement with those published for dTDP (24) and ␣-Qui4NAc (29) . Relatively large 3 J 2,3 , 3 J 3,4 , and 3 J 4,5 coupling constants (ca. 9 to 10 Hz) determined from the 1 H NMR spectrum are characteristic for the all-axial orientation of the Qui4NAc ring protons; hence, the sugar has the gluco configuration and is thus 4-acetamido-4,6-dideoxy-␣-D-glucose. The 31 P NMR spectrum contained signals for a diphosphate group at ␦ Ϫ11.1 and Ϫ12.7, which, as expected, showed strong correlations with the H-5Ј signal of dTDP at ␦ Ϫ11.1/4.18 and H-1 of ␣-Qui4NAc at ␦ Ϫ12.7/5.58 in the 1 H, 31 P heteronuclear multiquantum coherence spectrum. These data proved finally that the enzymatic product of VioB O7 is dTDP-D-QuiNAc, whose structure is depicted in Fig. 4 . The biosynthetic pathways for dTDP-DQui4N and dTDP-D-Qui4NAc are summarized in Fig. 5 .
Kinetic parameters for VioA D7 , VioA O7 , and VioB O7 . Kinetic parameters for the three enzymes investigated are listed in Table 3 . The kinetics of the reactions catalyzed by VioA D7 , VioA O7 , and VioB O7 fit reasonably well to the Michaelis-Menten model (Fig. S1 in the supplemental Determination of temperature optimum and shelf life for VioA D7 , VioA O7 , and VioB O7 . Activities of VioA D7 , VioA O7 , and VioB O7 at temperatures ranging from 4 to 75°C are shown in Fig. 6A . Different temperature effects were observed for VioA D7 and VioA O7 . For VioA O7 , the conversion rate increased along with a rise in temperature and reached to 90.3% at 75°C. For VioA D7 , the conversion rate was highest (90.7%) at 37°C and greatly decreased at 65°C and above. At lower temperatures ranging from 4 to 25°C, the conversion rate for VioA O7 was much lower than for VioA D7 . VioB O7 showed high activity over a wide temperature range from 4 to 65°C, with complete conversion at temperatures of 25, 37, and 50°C (Fig. 6A) . Conversion rates at temperatures above 75°C were not tested due to the instability of nucleotide-activated sugars at high temperatures, as indicated by the detection of the O7 . The inhibition of all cations was released when EDTA as the cation-chelating agent was added (data not shown). All those indicate that all three enzymes are divalent cation independent. EDTA also had no effect on the activities of all three enzymes (Fig. 6B) .
Analysis of amino donors for VioA D7 and VioA O7 . Seven amino acids, including L-Arg, L-Asp, L-Asn, L-Gly, L-Ala, LGln, and L-Glu, were tested as amino donors for the transamination reaction catalyzed by VioA D7 and VioA O7 (Fig. 6C ). High conversion rates for both VioA D7 (84.9%) and VioA O7 (84.5%) were obtained when L-Glu was utilized, and this is consistent with other PLP-dependent SATs (12) . L-Gln was also an effective amino donor for VioA D7 , with a 74.1% conversion rate being detected, but less effective for VioA O7 (15.9%). In addition, L-Ala could be used by both VioA enzymes and L-Gly by only VioA D7 as poor amino donors.
DISCUSSION
This is the first report on the characterization of the biosynthetic pathways for dTDP-D-Qui4N and dTDP-D-Qui4NAc. Genes encoding enzymes for all four reaction steps were functionally confirmed by in vitro experiments. Until now, functions of VioA and VioB have not unambiguously been defined. An early study reported purification of a SAT from E. coli strain B for the conversion of TDP-D-Glc4O to TDP-D-Qui4N; however, no structural verification of the enzyme product was carried out, and a putative gene was not proposed (21) . RmlA and RmlB catalyzing the first two steps of the pathways have been functionally identified in several other bacterial species (11, 30) . In this study, we confirmed the functions of RmlA and RmlB from S. dyenteriae type 7 and utilized those two enzymes to produce the substrate (dTDP-D-Glc4O) for the assay of D7 and VioA O7 catalyze the same transamination reaction. Sequence analysis reveals that the two SATs share 53% identity (67% similarity), which is much higher than the levels they share with other reported SATs (Table S1 in the supplemental material). Based on the position of the amino receptor, SATs can be divided into three subgroups acting on scylloinosose (1, 13, 14) , NDP-3-keto sugars (7, 23, 30, 35) , or NDP-4-keto sugars (2, 5, 12, 27, 34, 36) . This is also supported by the phylogenetic analysis of SATs (Fig. S2 in the supplemental  material) . As expected, VioA D7 and VioA O7 fall into the NDP-4-keto sugar subgroup but form a separate branch within the subgroup in the phylogenetic tree.
Sequence alignment of VioA D7 , VioA O7 , and other reported SATs reveals the substitution of amino acids at the potential activity sites in motifs II and IV in VioA O7 (Fig. 7) . A glycine residue in motif II is replaced by a serine residue in VioA O7 , and the same was found in StsC and TbmB, the glutamine: scyllo-inosose aminotransferases from Streptomycetes (1, 14) . A lysine residue in motif IV has been suggested to form a Schiff base with cofactor PLP (12) . In VioA O7 , we found two arginine residues and one lysine residue in tandem at the site. As in lysine, arginine also contains the ε-NH 2 group and is expected to contribute to the binding of PLP. This may explain the higher activity of VioA O7 , which has a K m value that is 20 times lower and a k cat /K m ratio that is about 150 times higher than those of VioA D7 . Furthermore, the K m of VioA O7 is the lowest among all kinetically characterized SATs, including Cj1294 (27), Cj1121c (36), WecE (12) , and RfbE (2). In future work, it is worthwhile to perform site-directed mutagenesis at the potential active sites to investigate any significance of amino acid substitution in relation to enzyme activity.
Having the maximum activity at 37°C while losing most of the activity at higher temperatures (65°C and above) for VioA D7 , but not for VioA O7 , may reflect the different niches occupied by Shigella and E. coli. Shigella strains live only inside the human intestine, and E. coli strains can adapt to various environmental niches, either inside or outside the human body. The activity of VioB O7 is also maintained over a wide temperature range.
Rare sugars are potentially useful in the pharmaceutical and chemical industries for drug development. Amino sugars have been reported as components of many macrolide antibiotics, including tylosin, desosamine, and erythromycin (7, 8, 23, 37) . Chemical synthesis of rare sugars is difficult due to the need for multistep reactions of protection and deprotection. This work provides genetic and biochemical means for the synthesis of Qui4N and Qui4NAc, which are not commonly found and are not yet commercially available.
